CCR 20th Anniversary Commentary: Molecular Pathology of ALK-Rearranged Lung Tumors
- PMID: 26626570
- DOI: 10.1158/1078-0432.CCR-14-3130
CCR 20th Anniversary Commentary: Molecular Pathology of ALK-Rearranged Lung Tumors
Abstract
The article by Rodig and colleagues, which was published in the August 15, 2009, issue of Clinical Cancer Research, helped detail the clinicopathologic profile of ALK-positive tumors and initiated the development of ALK diagnostics. Subsequent clinical trials utilized these findings, resulting in the approval of effective targeted therapies. The ALK story is a model for the development of therapies in the genomic era.
©2015 American Association for Cancer Research.
Comment on
-
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.Clin Cancer Res. 2009 Aug 15;15(16):5216-23. doi: 10.1158/1078-0432.CCR-09-0802. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671850 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
